French Hospitality Stock News

ENXTPA:KER
ENXTPA:KERLuxury

Is It Time To Reconsider Kering (ENXTPA:KER) After A 63% Five Year Share Price Fall

If you are wondering whether Kering at €242.00 is offering good value or still pricing in high expectations, the starting point is to see how its recent share performance lines up with what you are paying for. The stock has gained 2.2% over the past week and 0.8% over the past month, while the year to date return is down 20.6% and the 1 year return sits at 40.2%, with share price declines of 49.5% over 3 years and 63.5% over 5 years. These mixed returns frame a period where investors have...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

ABIVAX (ENXTPA:ABVX) Q1 Loss Of €48.5 Million Tests Bullish Growth Narratives

ABIVAX Société Anonyme (ENXTPA:ABVX) opened Q1 2026 with revenue of €1.3 million and a loss of €48.5 million, equivalent to EPS of €0.61. This sets a clear picture of a business still investing heavily for future potential rather than current profitability. Over recent quarters, the company has reported revenue between €0.6 million and €4.3 million, while quarterly EPS ranged from €0.61 to €2.10 and quarterly net losses moved between €39.4 million and €153.4 million. This gives investors a...
ENXTPA:OR
ENXTPA:ORPersonal Products

A Look At L'Oréal (ENXTPA:OR) Valuation As The 2026 Big Bang Beauty Tech Program Launches

L'Oréal (ENXTPA:OR) has opened the 2026 Big Bang Beauty Tech Innovation Program, focusing on AI powered commerce, creator ecosystems, and sustainability, which has prompted fresh investor attention on how this approach might relate to the stock. See our latest analysis for L'Oréal. Despite the renewed focus on beauty tech and AI, L'Oréal's share price return has been softer recently, with the 30 day share price return down 4.19% and the 90 day share price return down 8.93%. The 5 year total...
ENXTPA:MEDCL
ENXTPA:MEDCLPharmaceuticals

How Investors May Respond To MedinCell (ENXTPA:MEDCL) After EMA Accepts TEV-749 Schizophrenia Filing

Teva Pharmaceuticals International GmbH and MedinCell have announced that the European Medicines Agency has accepted their Marketing Authorization Application for TEV-749, a once-every-four-weeks subcutaneous olanzapine long-acting injectable for adult schizophrenia, supported by Phase 3 SOLARIS efficacy and safety data. The filing showcases MedinCell’s SteadyTeq copolymer delivery technology in a major psychiatric indication, potentially broadening the clinical and commercial reach of its...
ENXTPA:RMS
ENXTPA:RMSLuxury

A Look At Hermès International (ENXTPA:RMS) Valuation After Recent Share Price Weakness

Hermès International stock performance snapshot Hermès International Société en commandite par actions (ENXTPA:RMS) has drawn investor attention after a period of mixed share performance, with the stock down about 2% over the past month and roughly 24% over the past 3 months. See our latest analysis for Hermès International Société en commandite par actions. At a share price of €1,605.0, Hermès International’s recent 1-day and 7-day share price returns sit in contrast to a much weaker 90-day...
ENXTPA:TKO
ENXTPA:TKOCapital Markets

A Look At Tikehau Capital’s Valuation As Mixed Returns Meet An 18.7% Estimated Discount

What recent returns say about Tikehau Capital (ENXTPA:TKO) Tikehau Capital (ENXTPA:TKO) has delivered mixed share price performance, with the stock up 2.5% in the past day, slightly down over the past week and month, but positive over the past 3 months and year to date. See our latest analysis for Tikehau Capital. Putting this in context, the share price has positive momentum year to date, with a 13.29% year to date share price return. However, the 1 year total shareholder return is down...
ENXTPA:NEX
ENXTPA:NEXElectrical

Nexans AGM Resolutions Shape Dividend Policy And Board Oversight

Nexans (ENXTPA:NEX) held its Annual General Meeting, where shareholders approved all 22 proposed resolutions. The agenda included a dividend increase, the appointment of two new independent Directors, and the renewal of several existing board members. These decisions represent a significant update to the company’s governance framework. Nexans, listed as ENXTPA:NEX, operates in the cable and connectivity sector, supplying infrastructure for energy and data networks. The broad approval of AGM...
ENXTPA:RNO
ENXTPA:RNOAuto

A Look At Renault (ENXTPA:RNO) Valuation After Landmark Dual Tranche Samurai Bond Issue

Renault (ENXTPA:RNO) has just tapped Japan’s Samurai bond market with a ¥159 billion dual tranche issue, split between retail and institutional investors, offering 3.02% coupons on bonds maturing in 2030. See our latest analysis for Renault. The Samurai bond issuance comes at a time when the stock has seen the share price fall 10.96% over the past month and 23.38% year to date, with a 1 year total shareholder return decline of 36.97%. Investors appear to be weighing funding moves like this...
ENXTPA:AL2SI
ENXTPA:AL2SITech

A Look At 2CRSI (ENXTPA:AL2SI) Valuation After Sector-Driven AI Infrastructure Rally

Sector-driven rally puts 2CRSI in focus 2CRSI (ENXTPA:AL2SI) moved higher after a broad rally in French semiconductor stocks, as enthusiasm around AI infrastructure, datacenters, and high performance computing put extra attention on the company. See our latest analysis for 2CRSI. The recent 3.73% 1 day share price return at a €46.7 close caps a strong run, with a 20.8% 7 day share price return and a 310.37% year to date share price return contributing to a very large 1 year total shareholder...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

A Look At Sanofi (ENXTPA:SAN) Valuation After Positive ElevAATe Phase 2 AATD Emphysema Data

Why the ElevAATe data matters for Sanofi stock Sanofi (ENXTPA:SAN) has just put fresh clinical trial data in front of investors, with its ElevAATe phase 2 study showing that investigational efdoralprin alfa achieved normalized alpha-1 antitrypsin levels in AATD-related emphysema. The recombinant protein outperformed standard plasma-derived therapy on key efficacy measures and was reported as well tolerated, while fast track and orphan designations, plus active regulatory discussions, point to...
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

Assessing Exail Technologies (ENXTPA:EXA) Valuation After New Indian Navy Mine Counter-Measure Contract

Larsen & Toubro Limited and Exail Technologies (ENXTPA:EXA) have agreed to supply an Unmanned Mine Counter Measure Suite for the Indian Navy, positioning Exail as the technology partner on 12 planned Mine Counter Measure Vessels. See our latest analysis for Exail Technologies. After this announcement, Exail’s recent share price momentum has been firm, with a 7-day share price return of 7.96% and a year-to-date share price return of 45.01%, set against a very large 5-year total shareholder...
ENXTPA:TEP
ENXTPA:TEPProfessional Services

Assessing Teleperformance (ENXTPA:TEP) Valuation After A Recent Share Price Rebound

How Teleperformance Stock Has Been Moving Recently Teleperformance (ENXTPA:TEP) has drawn investor attention after a sharp shift in recent performance, with the stock up around 31% over the past month and about 41% over the past 3 months. See our latest analysis for Teleperformance. While the recent 31% 1 month share price return and 41% 3 month share price return at €73.26 suggest short term momentum is building, the 1 year total shareholder return is still down 17.7%, pointing to a more...
ENXTPA:UBI
ENXTPA:UBIEntertainment

Ubisoft Entertainment FY 2026 Loss Of €161 Million Rekindles Concerns Over Profitability Narratives

Ubisoft Entertainment (ENXTPA:UBI) has kicked off FY 2026 with first half revenue of €657.8 million and a basic EPS loss of €1.23, while the trailing twelve months show revenue of €1.89 billion and a basic EPS loss of €0.57. Over recent reporting periods, revenue has moved between €671.9 million in the first half of FY 2025 and €1.23 billion in the second half of FY 2025, with net income swinging from a loss of €246.7 million to a profit of €87.7 million, before reverting to a €161.3 million...
ENXTPA:AF
ENXTPA:AFAirlines

Flying Blue Bilt Expansion Tests Loyalty Value For Air France KLM Investors

Air France-KLM's Flying Blue loyalty program has expanded its rental rewards partnership with Bilt. Air France KLM Visa Signature cardholders can now earn extra Flying Blue Miles on rent payments made through Bilt. The move increases earning options for Bilt members and may strengthen Flying Blue's presence in the U.S. loyalty market. For investors watching ENXTPA:AF, this loyalty expansion lands at a time when the stock trades around €10.19. The share price comes after a mixed return...
ENXTPA:STMPA
ENXTPA:STMPASemiconductor

STMicroelectronics Links Low Power Imaging To AI Data Center Growth

STMicroelectronics (ENXTPA:STMPA) has introduced a new line of ultralow-power global-shutter image sensors targeted at wearables and personal electronics. The company also announced an expanded collaboration with Amazon Web Services focused on AI data center solutions. These developments highlight a push into energy-sensitive imaging for AR/VR, smart devices and medical tech, alongside a bigger role in AI infrastructure. STMicroelectronics enters this news cycle with its stock at €55.27 and...
ENXTPA:BN
ENXTPA:BNFood

Danone Exits Lifeway Stake Raising Questions Over US Functional Dairy Focus

Danone (ENXTPA:BN) plans to exit its long-held stake in Lifeway Foods, bringing an end to years of investment in the US kefir producer. The decision closes a chapter of attempted acquisitions and legal disputes between the companies. The move affects Danone's exposure to the fermented dairy and functional foods segment in the US. For you as an investor, this highlights how Danone positions ENXTPA:BN within fermented dairy and broader functional foods. The company has been active in...
ENXTPA:ARG
ENXTPA:ARGIndustrial REITs

Assessing Argan (ENXTPA:ARG) Valuation After CELIO Logistics Expansion And ESG-Focused Upgrades

Argan (ENXTPA:ARG) has just delivered a 12,000 sq.m extension to CELIO’s logistics site in Amblainville, taking the facility to 55,000 sq.m and integrating its AutOnom label energy performance features. See our latest analysis for Argan. Despite the CELIO extension underscoring Argan’s role in prime logistics and ESG aligned assets, the stock’s recent momentum has softened, with a 90 day share price return down 10.92% and a 1 year total shareholder return of 4.62% from a latest share price of...
ENXTPA:BNP
ENXTPA:BNPBanks

Is It Too Late To Consider Buying BNP Paribas (ENXTPA:BNP) After Recent Share Price Gains?

If you are wondering whether BNP Paribas offers good value at the current share price, or if the easier gains may already have been realized, this article explains what the numbers are indicating about the stock. The share price closed at €89.28, with returns of 9.0% year to date and 18.5% over the past year, although it has declined 2.3% over the last week and 3.6% over the last month. Recent coverage of European banks has focused on capital requirements, interest rate expectations and how...
ENXTPA:AM
ENXTPA:AMAerospace & Defense

Assessing Dassault Aviation (ENXTPA:AM) Valuation After The New VORTEX S Spaceplane Collaboration With OHB

Dassault Aviation société anonyme (ENXTPA:AM) is back in focus after announcing a collaboration with OHB on the proposed VORTEX-S multipurpose spaceplane project for the European Space Agency, further linking the stock to Europe’s space mobility plans. See our latest analysis for Dassault Aviation société anonyme. The VORTEX-S announcement comes after a stretch where the stock’s short term share price return has cooled, with a 30 day share price return down 11.73% and a 90 day share price...